
Anna Pagonakis
Examiner (ID: 15443, Phone: (571)270-3505 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 6221, 1628, OPET, 4173, 1614, 1609 |
| Total Applications | 1249 |
| Issued Applications | 445 |
| Pending Applications | 84 |
| Abandoned Applications | 723 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10069587
[patent_doc_number] => 09107922
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-18
[patent_title] => 'Pyrimidinecarboxamide derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/808508
[patent_app_country] => US
[patent_app_date] => 2011-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9666
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13808508
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/808508 | Pyrimidinecarboxamide derivatives | Jul 12, 2011 | Issued |
Array
(
[id] => 7720895
[patent_doc_number] => 20120010230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-12
[patent_title] => 'METHODS AND COMPOSITIONS FOR IDENTIFICATION, ASSESSMENT AND TREATMENT OF CANCERS ASSOCIATED WITH HEDGEHOG SIGNALING'
[patent_app_type] => utility
[patent_app_number] => 13/179438
[patent_app_country] => US
[patent_app_date] => 2011-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 59101
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20120010230.pdf
[firstpage_image] =>[orig_patent_app_number] => 13179438
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/179438 | METHODS AND COMPOSITIONS FOR IDENTIFICATION, ASSESSMENT AND TREATMENT OF CANCERS ASSOCIATED WITH HEDGEHOG SIGNALING | Jul 7, 2011 | Abandoned |
Array
(
[id] => 9004405
[patent_doc_number] => 20130225530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-29
[patent_title] => 'WOGONIN FOR THE PREVENTION AND THERAPY OF CARDIAC HYPERTROPHY'
[patent_app_type] => utility
[patent_app_number] => 13/809312
[patent_app_country] => US
[patent_app_date] => 2011-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7724
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13809312
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/809312 | WOGONIN FOR THE PREVENTION AND THERAPY OF CARDIAC HYPERTROPHY | Jul 5, 2011 | Abandoned |
Array
(
[id] => 8792730
[patent_doc_number] => 20130109699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-02
[patent_title] => 'TETRAHYDROCARBOLINE DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 13/807947
[patent_app_country] => US
[patent_app_date] => 2011-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 95025
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13807947
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/807947 | Tetrahydrocarboline derivative | Jul 4, 2011 | Issued |
| 13/174780 | NOVEL SOLID FORMS OF TACEDINALINE | Jun 30, 2011 | Abandoned |
Array
(
[id] => 11767848
[patent_doc_number] => 09376424
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-28
[patent_title] => 'Methods for treating post traumatic stress disorder'
[patent_app_type] => utility
[patent_app_number] => 13/807613
[patent_app_country] => US
[patent_app_date] => 2011-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 37791
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13807613
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/807613 | Methods for treating post traumatic stress disorder | Jun 30, 2011 | Issued |
Array
(
[id] => 8228573
[patent_doc_number] => 20120142780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-07
[patent_title] => 'USE OF 2,5-DIHYDROXYBENZENESULFONIC ACID IN THE MANUFACTURING OF MEDICINES, APPLICABLE TO THE TREATMENT OF ANGIODEPENDENT DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/169781
[patent_app_country] => US
[patent_app_date] => 2011-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5827
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13169781
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/169781 | Use of 2,5-dihydroxybenzenesulfonic acid in the manufacturing of medicines, applicable to the treatment of angiodependent diseases | Jun 26, 2011 | Issued |
Array
(
[id] => 8792756
[patent_doc_number] => 20130109726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-02
[patent_title] => 'SUSTAINED-RELEASE THERAPEUTIC AGENT FOR HYPERTENSION AND RENAL DYSFUNCTION'
[patent_app_type] => utility
[patent_app_number] => 13/806370
[patent_app_country] => US
[patent_app_date] => 2011-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3198
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13806370
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/806370 | SUSTAINED-RELEASE THERAPEUTIC AGENT FOR HYPERTENSION AND RENAL DYSFUNCTION | Jun 23, 2011 | Abandoned |
Array
(
[id] => 7662259
[patent_doc_number] => 20110311528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'USE OF 2,5-DIHYDROXYBENZENE COMPOUNDS AND DERIVATIVES FOR THE TREATMENT OF PSORIASIS'
[patent_app_type] => utility
[patent_app_number] => 13/166569
[patent_app_country] => US
[patent_app_date] => 2011-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 15243
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20110311528.pdf
[firstpage_image] =>[orig_patent_app_number] => 13166569
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/166569 | Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of psoriasis | Jun 21, 2011 | Issued |
Array
(
[id] => 7487912
[patent_doc_number] => 20110251250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-13
[patent_title] => 'USE OF DIMIRACETAM IN THE TREATMENT OF CHRONIC PAIN'
[patent_app_type] => utility
[patent_app_number] => 13/166088
[patent_app_country] => US
[patent_app_date] => 2011-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5405
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0251/20110251250.pdf
[firstpage_image] =>[orig_patent_app_number] => 13166088
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/166088 | Use of dimiracetam in the treatment of chronic pain | Jun 21, 2011 | Issued |
Array
(
[id] => 7733607
[patent_doc_number] => 20120015964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'QUINAZOLINONES AS INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA'
[patent_app_type] => utility
[patent_app_number] => 13/163597
[patent_app_country] => US
[patent_app_date] => 2011-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41624
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20120015964.pdf
[firstpage_image] =>[orig_patent_app_number] => 13163597
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/163597 | QUINAZOLINONES AS INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA | Jun 16, 2011 | Abandoned |
Array
(
[id] => 9286239
[patent_doc_number] => 08642568
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-04
[patent_title] => 'Method of diagnosing and therapeutically treating a patient for a traumatic brain injury'
[patent_app_type] => utility
[patent_app_number] => 13/160735
[patent_app_country] => US
[patent_app_date] => 2011-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 2863
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13160735
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/160735 | Method of diagnosing and therapeutically treating a patient for a traumatic brain injury | Jun 14, 2011 | Issued |
Array
(
[id] => 8884914
[patent_doc_number] => 20130158098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-20
[patent_title] => 'Alkenyl Substituted Cycloaliphatic Compounds as Chemical Inducers of Proximity'
[patent_app_type] => utility
[patent_app_number] => 13/704517
[patent_app_country] => US
[patent_app_date] => 2011-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 25434
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13704517
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/704517 | Alkenyl Substituted Cycloaliphatic Compounds as Chemical Inducers of Proximity | Jun 14, 2011 | Abandoned |
Array
(
[id] => 8516755
[patent_doc_number] => 20120316164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-13
[patent_title] => 'METHOD FOR INHIBITING THE GROWTH OF CANCER STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/158783
[patent_app_country] => US
[patent_app_date] => 2011-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4144
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13158783
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/158783 | METHOD FOR INHIBITING THE GROWTH OF CANCER STEM CELLS | Jun 12, 2011 | Abandoned |
Array
(
[id] => 7490322
[patent_doc_number] => 20110237572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/157893
[patent_app_country] => US
[patent_app_date] => 2011-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42944
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20110237572.pdf
[firstpage_image] =>[orig_patent_app_number] => 13157893
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/157893 | Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives | Jun 9, 2011 | Abandoned |
Array
(
[id] => 7490757
[patent_doc_number] => 20110237672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'Use of a cysteine-containing substance to increase the ventilatory activity and erythropoietin production'
[patent_app_type] => utility
[patent_app_number] => 13/155627
[patent_app_country] => US
[patent_app_date] => 2011-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2342
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20110237672.pdf
[firstpage_image] =>[orig_patent_app_number] => 13155627
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/155627 | Use of a cysteine-containing substance to increase the ventilatory activity and erythropoietin production | Jun 7, 2011 | Abandoned |
Array
(
[id] => 8932668
[patent_doc_number] => 08492367
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-23
[patent_title] => 'Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of rosacea'
[patent_app_type] => utility
[patent_app_number] => 13/154164
[patent_app_country] => US
[patent_app_date] => 2011-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 15178
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13154164
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/154164 | Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of rosacea | Jun 5, 2011 | Issued |
Array
(
[id] => 8721357
[patent_doc_number] => 20130072574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-21
[patent_title] => 'DIETARY SUPPLEMENTS CONTAINING EXTRACTS OF CINNAMON AND METHODS OF USING SAME TO PROMOTE ENHANCED SIRTUIN, CELL AND TELOMERE INTEGRITY'
[patent_app_type] => utility
[patent_app_number] => 13/699779
[patent_app_country] => US
[patent_app_date] => 2011-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12568
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699779
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/699779 | Dietary supplements containing extracts of cinnamon and methods of using same to promote enhanced sirtuin, cell and telomere integrity | May 25, 2011 | Issued |
Array
(
[id] => 7568044
[patent_doc_number] => 20110288107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-24
[patent_title] => 'TOPICAL FORMULATION FOR A JAK INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 13/112370
[patent_app_country] => US
[patent_app_date] => 2011-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16460
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0288/20110288107.pdf
[firstpage_image] =>[orig_patent_app_number] => 13112370
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/112370 | TOPICAL FORMULATION FOR A JAK INHIBITOR | May 19, 2011 | Abandoned |
Array
(
[id] => 7487714
[patent_doc_number] => 20110236506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'PHARMACEUTICAL ASSOCIATION CONTAINING LIPOIC ACID AND HYDROXYCITRIC ACID AS ACTIVE INGREDIENTS'
[patent_app_type] => utility
[patent_app_number] => 13/099897
[patent_app_country] => US
[patent_app_date] => 2011-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10763
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0236/20110236506.pdf
[firstpage_image] =>[orig_patent_app_number] => 13099897
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/099897 | PHARMACEUTICAL ASSOCIATION CONTAINING LIPOIC ACID AND HYDROXYCITRIC ACID AS ACTIVE INGREDIENTS | May 2, 2011 | Abandoned |